Active Ingredient History
Parecoxib, sold under the brand name Dynastat among others, is a water-soluble and injectable prodrug of valdecoxib. Parecoxib is a COX2 selective inhibitor. It is injectable. It is approved in the European Union for short term perioperative pain control. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Analgesia (Phase 4)
Analgesics, Opioid (Phase 4)
Anesthesia (Phase 4)
Anterior Cruciate Ligament Injuries (Phase 4)
Colic (Phase 3)
Drugs, Investigational (Phase 4)
Emergence Delirium (Phase 4)
Epigenomics (Phase 4)
Gastrointestinal Neoplasms (Phase 4)
General Surgery (Phase 4)
Gynecologic Surgical Procedures (Phase 4)
Hemangioma (Phase 4)
HIV Infections (Phase 4)
Hyperalgesia (Phase 4)
Inflammation (Phase 4)
Knee Injuries (Phase 4)
Neurosurgery (Phase 4)
Pain (Phase 4)
Pain, Postoperative (Phase 4)
Pain Threshold (Phase 4)
Pancreatitis (Phase 4)
Perioperative Care (Phase 4)
Pharyngitis (Phase 2)
Postoperative Complications (Phase 2/Phase 3)
Rib Fractures (Phase 3)
Shoulder Pain (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue